Results
Dhampur Bio Q2 Revenue Up 24% YoY to ₹665.5 Cr
• Investor presentation details Q2 FY27 standalone results with revenue of ₹665.5 Cr, up 24% YoY.
• PAT from continuing operations surged to ₹26.6 Cr from loss of ₹8.3 Cr YoY, with EBITDA up 364% to ₹
